Gambacorta, Maria Antonietta
 Distribuzione geografica
Continente #
NA - Nord America 13.075
EU - Europa 10.627
AS - Asia 10.336
SA - Sud America 1.953
AF - Africa 351
OC - Oceania 54
Continente sconosciuto - Info sul continente non disponibili 16
Totale 36.412
Nazione #
US - Stati Uniti d'America 12.681
SG - Singapore 4.639
DE - Germania 3.187
CN - Cina 2.038
SE - Svezia 1.655
BR - Brasile 1.586
IT - Italia 1.543
VN - Vietnam 1.130
FR - Francia 878
NL - Olanda 774
IN - India 640
GB - Regno Unito 515
IE - Irlanda 458
UA - Ucraina 370
FI - Finlandia 321
ID - Indonesia 308
JP - Giappone 280
HK - Hong Kong 267
BD - Bangladesh 240
PL - Polonia 203
RU - Federazione Russa 199
CA - Canada 186
TR - Turchia 140
AR - Argentina 138
IQ - Iraq 130
MX - Messico 130
AT - Austria 97
BE - Belgio 97
PK - Pakistan 85
ZA - Sudafrica 84
KR - Corea 68
CI - Costa d'Avorio 66
ES - Italia 64
CZ - Repubblica Ceca 59
EC - Ecuador 47
PH - Filippine 43
MA - Marocco 41
AU - Australia 40
CO - Colombia 40
SA - Arabia Saudita 40
VE - Venezuela 38
IR - Iran 36
LT - Lituania 36
CL - Cile 31
KE - Kenya 30
CH - Svizzera 29
UZ - Uzbekistan 29
EG - Egitto 25
JO - Giordania 25
PE - Perù 24
IL - Israele 23
AE - Emirati Arabi Uniti 22
RO - Romania 21
TN - Tunisia 21
DZ - Algeria 20
UY - Uruguay 20
PY - Paraguay 19
MY - Malesia 18
GR - Grecia 17
AL - Albania 15
AZ - Azerbaigian 15
PA - Panama 15
KZ - Kazakistan 14
NZ - Nuova Zelanda 14
ET - Etiopia 13
JM - Giamaica 13
BG - Bulgaria 11
CR - Costa Rica 11
NP - Nepal 11
SN - Senegal 11
BH - Bahrain 10
NG - Nigeria 10
RS - Serbia 10
TW - Taiwan 10
AM - Armenia 9
DO - Repubblica Dominicana 9
HN - Honduras 9
PS - Palestinian Territory 9
TT - Trinidad e Tobago 9
BO - Bolivia 8
NO - Norvegia 8
OM - Oman 8
PT - Portogallo 8
TH - Thailandia 8
A2 - ???statistics.table.value.countryCode.A2??? 7
DK - Danimarca 7
EU - Europa 7
GE - Georgia 7
HU - Ungheria 7
KG - Kirghizistan 6
LK - Sri Lanka 6
NI - Nicaragua 6
AO - Angola 5
MD - Moldavia 5
MN - Mongolia 5
MT - Malta 5
BY - Bielorussia 4
LB - Libano 4
LV - Lettonia 4
SC - Seychelles 4
Totale 36.348
Città #
Singapore 2.622
Chandler 1.765
San Jose 1.311
Ashburn 1.234
Amsterdam 708
New York 506
Beijing 462
Dublin 455
Ho Chi Minh City 401
Los Angeles 370
Rome 324
Frankfurt am Main 307
The Dalles 289
Lauterbourg 278
Ann Arbor 274
Hanoi 261
Jakarta 260
Tokyo 258
Milan 255
Jacksonville 254
Hyderabad 247
San Mateo 243
Munich 237
Hong Kong 232
Hefei 218
Wilmington 172
St Louis 164
São Paulo 156
Boston 148
Princeton 144
Warsaw 143
Helsinki 138
Nanjing 135
Nürnberg 131
Dallas 125
Houston 123
Moscow 119
Marseille 118
Chicago 113
Bremen 112
Cattolica 112
Dearborn 109
Woodbridge 103
Santa Clara 96
Council Bluffs 94
Fairfield 94
Brussels 90
Buffalo 87
Redwood City 81
London 80
Seattle 73
Da Nang 71
Brooklyn 68
Orem 67
Abidjan 66
Lawrence 66
Seoul 63
Turku 63
Boardman 62
Nuremberg 62
Kent 58
Atlanta 57
Toronto 55
Izmir 53
Denver 51
Paris 50
Phoenix 50
Montreal 49
Nanchang 49
Vienna 49
Washington 48
Chennai 47
Düsseldorf 47
Leawood 47
Haiphong 46
Lappeenranta 45
Johannesburg 44
Rio de Janeiro 43
Stockholm 43
Baghdad 42
Zhengzhou 41
North Bergen 40
Poplar 39
Shenyang 38
Mexico City 37
Detroit 36
Augusta 35
Brno 35
Manchester 33
Falkenstein 32
Guangzhou 32
Shanghai 32
Columbus 31
Falls Church 30
Norwalk 30
Pune 30
San Francisco 30
Tianjin 30
Belo Horizonte 29
Dhaka 28
Totale 19.060
Nome #
Does restaging MRI radiomics analysis improve pathological complete response prediction in rectal cancer patients? A prognostic model development 948
THUNDER 2: THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI guided radiotherapy 517
Contact skin radiotherapy (brachytherapy) for the treatment of non-melanoma skin cancers during COVID-19 pandemic 510
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 376
A digital solution to support the activities: Multidisciplinary Tumor Board process and impact analysis 321
Diffusion-Weighted Magnetic Resonance Imaging in Monitoring Rectal Cancer Response to Neoadjuvant Chemoradiotherapy. 269
Rectal cancer multidisciplinary treatment: evidences, consensus and perspectives. 231
Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies 228
Diagnosis and treatment of bone metastases in breast cancer: Radiotherapy, local approach and systemic therapy in a guide for clinicians 225
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 222
Automatic delineation for replanning in nasopharynx radiotherapy: what is the agreement among experts to be considered as benchmark? 221
Multimodality treatment of unresectable stage III non small cell lung cancer: interim analysis of a phase II trial using preoperative gemcitabine with concurrent radiotherapy 220
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 219
Efficacy of a new technique - INtubate-RECruit-SURfactant-Extubate - "IN-REC-SUR-E" - in preterm neonates with respiratory distress syndrome: study protocol for a randomized controlled trial. 211
Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer: short-term morbidity and functional outcome. 210
Medicine is a science of uncertainty and an art of probability (Sir W. Osler) 210
Infusional 5-fluorouracil and ZD1839 (Gefitinib-Iressa) in combination with preoperative radiotherapy in patients with locally advanced rectal cancer: a phase I and II Trial (1839IL/0092) 208
Impact of Radiotherapy on Pain Relief and Recalcification in Plasma Cell Neoplasms : Long-Term Experience. 200
Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. 198
Lung recruitment strategies and surfactant in neonatal intensive care unit 198
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 198
Oncotype DX Predictive Nomogram for Recurrence Score Output: The Novel System ADAPTED01 Based on Quantitative Immunochemistry Analysis 193
Outcomes of clinical t4m0 extra-peritoneal rectal cancer treated with preoperative radiochemotherapy and surgery: a prospective evaluation of a single institutional experience. 191
Low-dose fractionated radiotherapy and concomitant chemotherapy for recurrent or progressive glioblastoma: final report of a pilot study 190
Evaluation of early regression index as response predictor in cervical cancer: A retrospective study on T2 and DWI MR images 189
Is two-dimensional field definition sufficient for pelvic node coverage in rectal cancer compared to technical three-dimensional definition? 189
Clinical validation of atlas-based auto-segmentation of pelvic volumes and normal tissue in rectal tumors using auto-segmentation computed system 182
Outcomes of clinical T4M0 extra-peritoneal rectal cancer treated with preoperative radiochemtoherapy and surgery. A prospective evalation of a single institutional experience. 181
Generator breast datamart—the novel breast cancer data discovery system for research and monitoring: Preliminary results and future perspectives 181
International consensus guidelines on Clinical Target Volume delineation in rectal cancer 179
Patients’ Satisfaction by SmileInTM Totems in Radiotherapy: A Two-Year Mono-Institutional Experience 178
Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemoterapy and radioation therapy 177
Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant chemoradiotherapy 177
The predictive value of 18F-FDG PET/CT for assessing pathological response and survival in locally advanced rectal cancer after neoadjuvant radiochemotherapy 177
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 176
Evidence and research perspectives for surgeons in the European Rectal Cancer Consensus Conference (EURECA-CC2). 175
Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. 171
MRI anatomy of parametrial extension to better identify local pathways of disease spread in cervical cancer 171
THeragnostic utilities for neoplastic DisEases of the rectum by MRI guided radiotherapy (THUNDER 2) phase II trial: interim safety analysis 170
Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study 169
The assisi think tank meeting breast large database for standardized data collection in breast cancer—attm.Blade 167
Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience 164
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 163
MRI anatomy of parametrial extension to better identify local pathways of disease spread in cervical cancer. 162
Functional results of exclusive interventional radiotherapy (brachytherapy) in the treatment of nasal vestibule carcinomas 157
Hepatic Radiotherapy in Addition to Anti-PD-1 for the Treatment of Metastatic Uveal Melanoma Patients 154
Nomogram for predicting radiation maculopathy in patients treated with Ruthenium-106 plaque brachytherapy for uveal melanoma 154
Management of oligometastatic ovarian cancer recurrence during PARP inhibitor maintenance 152
Assessing Quality of Life with the Novel QLQ-CAX24 Questionnaire and Body Composition Parameters in Rectal Cancer Patients: A Single-Center Prospective Study 152
Delta radiomics for rectal cancer response prediction with hybrid 0.35 T magnetic resonance-guided radiotherapy (MRgRT): a hypothesis-generating study for an innovative personalized medicine approach 152
Ruthenium brachytherapy for uveal melanomas: Factors affecting the development of radiation complications 151
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 151
Interventional radiotherapy as exclusive treatment for primary nasal vestibule cancer: Single-institution experience 151
191P Radiotherapy (RT) in oligoprogressive metastatic breast cancer (mBC): A retrospective analysis 151
BRIDGE -1 TRIAL: BReak Interval Delayed surgery for Gastrointestinal Extraperitoneal rectal cancer, a multicentric phase III randomized trial 150
The Role of Simultaneous Integrated Boost in Locally Advanced Rectal Cancer Patients with Positive Lateral Pelvic Lymph Nodes 150
Improved outcomes for rectal cancer in the era of preoperative chemoradiation and tailored mesorectal excision: a series of 338 consecutive cases 149
An umbrella protocol for standardized data collection (SDC) in rectal cancer: a prospective uniform naming and procedure convention to support personalized medicine 149
PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to predict partial response in locally advanced cervical cancer patients undergoing chemoradiation and radical surgery 149
Project for interventional Oncology LArge-database in liveR Hepatocellular carcinoma - Preliminary CT-based radiomic analysis (POLAR Liver 1.1) 149
The role of 18F-FDG-PET/CT in predicting the histopathological response in locally advanced cervical carcinoma treated by chemo-radiotherapy followed by radical surgery: a prospective study 147
A field strength independent MR radiomics model to predict pathological complete response in locally advanced rectal cancer 147
The impact of radiomics in diagnosis and staging of pancreatic cancer 147
MRI-derived radiomics to guide post-operative management of glioblastoma: Implication for personalized radiation treatment volume delineation 146
Delta Radiomics Analysis for Local Control Prediction in Pancreatic Cancer Patients Treated Using Magnetic Resonance Guided Radiotherapy 146
The INTER-ROMA project--a survey among Italian radiation oncologists on their approach to the treatment of bone metastases 145
Low-dose radiotherapy and concurrent FOLFIRI-bevacizumab: A Phase II study 145
INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures 145
The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic disease 143
MOREOVER: multiomics MR-guided radiotherapy optimization in locally advanced rectal cancer 142
Nomogram predicting response after chemoradiotherapy in rectal cancer using sequential PETCT imaging: A multicentric prospective study with external validation. 141
Virtual simulation:fifteen years later 140
The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic disease 140
Magnetic resonance–guided radiotherapy feasibility in elderly cancer patients: proposal of the MASTER scoring system 140
Integration of art and technology in personalized radiation oncology care: Experiences, evidence, and perspectives 139
Concurrent Chemoradiation with Concomitant Boost in Locally Advanced Rectal Cancer: A Phase II Study 139
Radiotherapy benefit in oligoprogressive breast cancer: A retrospective analysis 139
A deep learning approach to generate synthetic CT in low field MR-guided radiotherapy for lung cases 138
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 138
EROS study: Evaluation between high-dose-rate and low-dose-rate vaginal interventional radiotherapy (brachytherapy) in terms of overall survival and rate of stenosis 138
Multidisciplinary Tumor Board Smart Virtual Assistant in Locally Advanced Cervical Cancer: A Proof of Concept 138
Radiomics-based prediction of two-year clinical outcome in locally advanced cervical cancer patients undergoing neoadjuvant chemoradiotherapy 138
The Italian version of the Pediatric Quality of Life Inventory™ (PEDSQL™) 3.0 healthcare satisfaction hematology/oncology module: reliability and validity in radiation oncology 138
Palliative short-course radiation therapy in rectal cancer: A phase 2 study 137
INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures 137
Dabrafenib-Trametinib and Radiotherapy for Oligoprogressive BRAF Mutant Advanced Melanoma 136
Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients. 136
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial 136
Pain REduction with bone metastases STereotactic radiotherapy (PREST): A phase III randomized multicentric trial 136
May we routinely spare hippocampal region in primary central nervous system lymphoma during whole brain radiotherapy? 135
Neo-adjuvant platinum-based chemotherapy followed by chemoradiation and radical surgery in locally advanced cervical cancer (Lacc) patients: A phase II study 134
EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum 133
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 133
Automatic segmentation software in locally advanced rectal cancer: READY (REsearch program in Auto Delineation sYstem)-RECTAL 02: prospective study 133
Modern Management of Esophageal Cancer: Radio-Oncology in Neoadjuvancy, Adjuvancy and Palliation 133
Standardized data collection to build prediction models in oncology: A prototype for rectal cancer 132
Developing and validating ultrasound-based radiomics models for predicting high-risk endometrial cancer 132
Current practices and perspectives on the integration of contrast agents in MRI-guided radiation therapy clinical practice: A worldwide survey 131
An IT Platform Supporting Rectal Cancer Tumor Board Activities: Implementation Process and Impact Analysis 131
Art and digital technologies to support resilience during the oncological journey: The Art4ART project 130
Totale 18.167
Categoria #
all - tutte 149.325
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 149.325


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202147 0 0 0 0 0 0 0 0 0 0 0 47
2021/20222.000 179 77 35 163 84 68 32 266 132 142 440 382
2022/20234.910 641 644 369 762 272 584 257 388 575 153 189 76
2023/20242.637 106 684 127 185 129 460 164 94 31 95 274 288
2024/20255.795 112 149 411 219 582 230 233 228 764 696 1.230 941
2025/202616.494 2.028 447 871 1.699 2.522 2.298 2.640 888 972 1.160 633 336
Totale 36.928